HomeCompareCVET vs PLD

CVET vs PLD: Dividend Comparison 2026

CVET yields 9.53% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.47M in total portfolio value· pulled ahead in Year 3
10 years
CVET
CVET
● Live price
9.53%
Share price
$20.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.6K
Annual income
$1,735.75
Full CVET calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CVET vs PLD

📍 PLD pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVETPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVET + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CVET pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVET
Annual income on $10K today (after 15% tax)
$809.91/yr
After 10yr DRIP, annual income (after tax)
$1,475.39/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,466,495.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVET + PLD for your $10,000?

CVET: 50%PLD: 50%
100% PLD50/50100% CVET
Portfolio after 10yr
$3.27M
Annual income
$2,629,085.96/yr
Blended yield
80.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CVET
Analyst Ratings
1
Hold
Consensus: Hold
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVET buys
0
PLD buys
0
No recent congressional trades found for CVET or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVETPLD
Forward yield9.53%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$37.6K$6.50M
Annual income after 10y$1,735.75$5,256,436.18
Total dividends collected$13.4K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: CVET vs PLD ($10,000, DRIP)

YearCVET PortfolioCVET Income/yrPLD PortfolioPLD Income/yrGap
1$11,653$952.83$11,255$555.24+$398.00CVET
2$13,506$1,037.68$13,062$1,018.59+$444.00CVET
3← crossover$15,576$1,124.05$15,903$1,926.67$327.00PLD
4$17,877$1,211.47$20,839$3,823.32$3.0KPLD
5$20,428$1,299.54$30,464$8,166.08$10.0KPLD
6$23,246$1,387.82$52,054$19,457.30$28.8KPLD
7$26,349$1,475.94$109,886$54,188.93$83.5KPLD
8$29,757$1,563.52$304,030$186,451.18$274.3KPLD
9$33,491$1,650.22$1,166,125$840,813.32$1.13MPLD
10$37,571$1,735.75$6,504,190$5,256,436.18$6.47MPLD

CVET vs PLD: Complete Analysis 2026

CVETStock

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Full CVET Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CVET vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVET vs SCHDCVET vs JEPICVET vs OCVET vs KOCVET vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.